Oncology & Cancer

A novel tissue imaging system accelerates cancer diagnosis

Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick and early detection of cancers. In a new study, researchers from Osaka University developed a novel imaging system that ...

Oncology & Cancer

Study 'strongly supports' extending cervical screening intervals

Screening for high risk human papillomavirus (HR-HPV) infection works well in practice and is more sensitive than cytology (smear) testing—offering greater protection against cervical cancer, confirm researchers in The ...

Oncology & Cancer

Study tests new vaccine for precancerous cervical cells

Vanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeutic vaccine for treating women with precancerous changes on the cervix.

Obstetrics & gynaecology

At-home self-collected samples valid for detecting high-risk HPV

(HealthDay)—Mail-based, at-home self-collection of cervicovaginal samples is valid for detecting high-risk human papillomavirus (HPV) among infrequently screened women, according to a study published online Nov. 5 in Obstetrics ...

Oncology & Cancer

HPV cervical CA screening cuts odds of later CIN3+ diagnosis

(HealthDay)—The use of primary human papillomavirus (HPV) testing versus cytology results in reduced likelihood of cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+) at 48 months, according to a study published ...

Oncology & Cancer

Risk of CIN3 drops with negative HPV, cytology co-tests

(HealthDay)—The five-year risks of cervical intraepithelial neoplasia grade 3 (CIN3), adenocarcinoma in situ, and cervical cancer (≥CIN3) decrease after each successive negative human papillomavirus (HPV) and cytology ...

page 1 from 3